TrialJournal of child and adolescent psychopharmacology2022

Efficacy and Safety of Dextroamphetamine Transdermal System for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results from a Pivotal Phase 2 Study.

Andrew J Cutler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.